HPS Pharmacies wish to give notice that suppliers are experiencing a supply interruption for bromhexine oral liquid products, including:

  • Bisolvon® Chesty (0.8mg/mL)
  • Bisolvon® Chesty Kids (0.8mg/mL)
  • Duro-Tuss® Chesty (0.8mg/mL)
  • Bisolvon® Chesty Forte (1.6mg/mL)
  • Duro-Tuss® Chesty Double Strength (1.6mg/mL)
  • Apohealth® Chesty Mucus Relief Forte (1.6mg/mL)

An estimated return date for normal supply is not yet available for all brands. However, Bisolvon Chesty Forte® is expected to return to stock by the end of May 2023.

Bromhexine is currently available as an oral liquid in combination with guaifenesin e.g. Duro-Tuss Chesty Forte (bromhexine 0.8mg/mL + guaifenesin 20mg/mL). Bromhexine is also available as a single ingredient oral tablet.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates